Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plitidepsin plus dexamethasone vs dexamethasone in relapsed/refractory multiple myeloma
2009-016138-29Phase 3Completed
- Sponsor
- PharmaMar
- Start
- Mar 2010
- Modality
- Peptide-Drug Conjugates → Peptide Conjugates → Peptides, Cyclic Peptides → Modified Peptides → Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of plitidepsin in multiple myeloma (MM) (2 arms), sponsored by PharmaMar. Primary endpoint: Progression-free survival. Started Mar 2010; status: completed.
02
Drugs
plitidepsin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2009-016138-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016138-29.